← Back to Screener
McKesson Corporation (MCK)
Price$859.04
Favorite Metrics
Price vs S&P 500 (26W)4.72%
Price vs S&P 500 (4W)-11.69%
Market Capitalization$105.38B
P/E Ratio (Annual)31.98x
Indicated Dividend Yield (Annual)0.38%
All Metrics
P/CF (Annual)17.32x
Book Value / Share (Quarterly)$36.58
P/TBV (Annual)11.28x
Indicated Dividend (Annual)$3.28
Revenue Growth (3Y)10.80%
Cash Flow / Share (Quarterly)$78.41
Payout Ratio (TTM)8.55%
Price vs S&P 500 (YTD)1.48%
Gross Margin (TTM)3.48%
Net Profit Margin (TTM)1.09%
EPS (TTM)$34.77
10-Day Avg Trading Volume0.68M
EPS Excl Extra (TTM)$34.77
Revenue Growth (5Y)9.22%
EPS (Annual)$25.72
Dividend / Share (Annual)$2.71
ROI (Annual)7.21%
Gross Margin (Annual)3.60%
Net Profit Margin (5Y Avg)0.34%
Cash / Share (Quarterly)$24.06
P/E Basic Excl Extra (TTM)24.28x
Revenue Growth QoQ (YoY)11.40%
EPS Growth (5Y)39.07%
P/E Normalized (Annual)31.98x
ROA (Last FY)4.39%
Revenue Growth TTM (YoY)15.49%
EBITD / Share (TTM)$48.62
ROE (5Y Avg)17.95%
Operating Margin (TTM)1.42%
Cash Flow / Share (Annual)$41.81
P/B Ratio17.89x
P/B Ratio (Quarterly)4.06x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)0.27x
Net Interest Coverage (TTM)17.45x
ROA (TTM)5.34%
EPS Growth QoQ (YoY)38.09%
EV / EBITDA (TTM)17.95x
EPS Incl Extra (Annual)$25.72
Current Ratio (Annual)0.90x
Quick Ratio (Quarterly)0.46x
3-Month Avg Trading Volume0.73M
52-Week Price Return24.71%
EV / Free Cash Flow (Annual)20.85x
P/E Incl Extra (TTM)24.28x
Revenue / Employee (TTM)$9
Tangible BV / Share (Quarterly)$17.76
P/S Ratio (Annual)0.29x
Asset Turnover (Annual)4.78x
52-Week High$999.00
Operating Margin (5Y Avg)0.53%
EPS Excl Extra (Annual)$25.72
CapEx CAGR (5Y)11.17%
Tangible BV CAGR (5Y)-15.75%
26-Week Price Return13.47%
Quick Ratio (Annual)0.51x
13-Week Price Return3.86%
Total Debt / Equity (Annual)1.45x
Current Ratio (Quarterly)0.88x
Enterprise Value$108,980.08
Revenue / Share Growth (5Y)17.16%
Asset Turnover (TTM)4.90x
Book Value / Share Growth (5Y)-1.84%
Revenue / Employee (Annual)$8
Inventory Turnover (Annual)15.68x
Pretax Margin (Annual)1.21%
Cash / Share (Annual)$45.53
3-Month Return Std Dev40.42%
Gross Margin (5Y Avg)4.47%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)9.08%
ROE (Last FY)17.67%
Net Interest Coverage (Annual)25.20x
EPS Basic Excl Extra (Annual)$25.72
P/FCF (TTM)9.80x
Receivables Turnover (TTM)14.73x
EV / Free Cash Flow (TTM)11.30x
Total Debt / Equity (Quarterly)1.29x
EPS Incl Extra (TTM)$34.77
Receivables Turnover (Annual)16.26x
ROI (TTM)16.23%
Dividend Growth Rate (5Y)10.13%
P/S Ratio (TTM)0.26x
Pretax Margin (5Y Avg)0.55%
Revenue / Share (Annual)$2802.90
Tangible BV / Share (Annual)$11.95
Forward P/E22.03x
Free OCF CAGR (5Y)6.20%
Price vs S&P 500 (52W)-10.38%
P/E Ratio (TTM)24.28x
EPS Growth TTM (YoY)59.37%
Year-to-Date Return5.62%
5-Day Price Return0.21%
EPS Normalized (Annual)$25.72
ROA (5Y Avg)1.87%
Net Profit Margin (Annual)0.92%
Month-to-Date Return0.12%
Cash Flow / Share (TTM)$31.05
EBITD / Share (Annual)$37.99
EPS Growth (3Y)52.67%
Operating Margin (Annual)1.23%
LT Debt / Equity (Annual)1.21x
P/CF (TTM)10.05x
ROI (5Y Avg)9.37%
P/E Excl Extra (TTM)24.28x
LT Debt / Equity (Quarterly)0.99x
EPS Basic Excl Extra (TTM)$34.77
P/TBV (Quarterly)8.36x
Payout Ratio (Annual)10.47%
P/B Ratio (Annual)4.29x
Dividend / Share (TTM)$2.98
Inventory Turnover (TTM)15.09x
Pretax Margin (TTM)1.40%
Book Value / Share (Annual)$31.43
Price vs S&P 500 (13W)1.00%
Net Margin Growth (5Y)18.73%
Dividend Yield (TTM)0.35%
Beta0.42x
P/FCF (Annual)20.16x
Revenue / Share (TTM)$3217.12
ROE (TTM)39.43%
52-Week Low$637.00
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.18
4.18
4.18
4.18
Industry Peers — Drug Wholesale(8)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Operating Margin (TTM) | Revenue Growth TTM (YoY) | Price |
|---|---|---|---|---|---|
MCKMcKesson Corporation | 31.98x | 39.43% | 1.42% | 15.49% | $859.04 |
CORCencora, Inc. | 41.00x | 101.43% | 0.82% | 7.45% | $323.01 |
CAHCardinal Health, Inc. | 31.87x | 37.17% | 1.04% | 10.13% | $211.18 |
HLFHerbalife Ltd. | 7.69x | 170.70% | -14.76% | 0.89% | $16.98 |
NUSNuSkin Enterprises, Inc. | 2.34x | 20.36% | 16.29% | -14.26% | $7.82 |
COSMCosmos Holdings Inc. Common Stock | — | -74.28% | -23.86% | 6.69% | $0.38 |
WGRXWellgistics Health, Inc. Common Stock | — | -1645.88% | -414.51% | 28.73% | $0.13 |
ZSTKZeroStack Corp. Common Stock | — | -332.01% | -339.14% | — | $7.42 |
HWHHWH International Inc. Common Stock | — | -88.53% | -326.05% | -30.84% | $1.14 |
About
McKesson Corp is one of three dominant pharmaceutical wholesalers in the United States, controlling a significant portion of the pharmaceutical distribution market alongside Cencora and Cardinal Health. The company sources and distributes branded, generic, and specialty pharmaceuticals to retail pharmacies, independent pharmacies, hospitals, and healthcare providers, while also supplying medical-surgical products and equipment to healthcare facilities. McKesson maintains operations in Canada for pharmaceutical distribution and offers technology solutions to pharmacy customers.